v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net earnings $ 181,862 $ 73,400 $ 168,105
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 97,359 109,903 111,711
Deferred income taxes 13,196 (51,107) (39,447)
Stock-based compensation expense 41,365 40,833 38,042
Fair value adjustment to contingent consideration payable     (3,500)
(Gain) Loss on equity method investment (887) (938) 6,841
Loss on investments 5,862    
Asset impairment restructuring 3,914 21,312 2,634
Leases, net (2,983) 685 1,708
(Recovery) Impairment of assets held-for-sale (6,789) 80,503 21,963
Other operating activity 477 1,426 1,030
Change in operating assets and operating liabilities:      
Trade accounts and other receivables, net (10,793) 34,132 (20,533)
Inventories (8,232) (18,144) (14,215)
Prepaid expenses 5,264 (14,372) (3,146)
Trade accounts payable, accrued expenses, contract liabilities, and other 3,180 (13,954) 25,769
Salaries, wages and related accruals (7,671) 15,408 12,618
Income taxes payable (23,051) 8,469 (10,599)
Net cash provided by operating activities 292,073 287,556 298,981
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from sale of available-for-sale investments   1,085 28,083
Purchases of available-for-sale investments     (5,526)
Additions to property and equipment (28,850) (31,006) (62,877)
Acquisitions, net of cash acquired     (169,707)
Distributions from Wilson Wolf 6,043 7,291 6,997
Investment in Spear Bio   (15,000)  
Proceeds from sale of assets held-for-sale 4,617 2,447  
Net cash used in investing activities (18,190) (35,183) (203,030)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Cash dividends (49,916) (50,391) (50,419)
Proceeds from stock option exercises 80,618 51,739 60,935
Repurchases of common stock (41,675) (275,731) (80,042)
Borrowings under line-of-credit agreement   104,000 225,000
Repayments of long-term debt (146,000) (77,000) (256,000)
Taxes paid on RSUs and net share settlements (12,141) (6,522) (21,872)
Net cash used in financing activities (169,114) (253,905) (122,398)
Effect of exchange rate changes on cash and cash equivalents (2,243) 11,927 (2,333)
Net change in cash and cash equivalents 102,526 10,395 (28,780)
Cash and cash equivalents at beginning of period 162,186 151,791 180,571
Cash and cash equivalents at end of period $ 264,712 $ 162,186 $ 151,791